Life sciences intelligence & strategy

Turn market signals into winning decisions.

Precision10X helps pharma, diagnostics, MedTech and consumer health leaders see competitors first, size opportunities with confidence and enter new markets, with deep expertise across Saudi Arabia, the UAE and the wider Middle East.

0+years of leadership experience
$0M+revenue opportunity identified for one client
0+assets tracked in a single CI programme
0regions: GCC, India, Europe, US, Southeast Asia
About Us

Built by industry leaders. Focused on your next decision.

Precision10X Marketing and Consultancy was founded by top industry leaders with more than 30 years of combined corporate experience across global pharma, diagnostics, MedTech and consumer health.

We have sat on the client side of the table. We know that leadership teams need clear answers rather than more data, so every engagement is senior-led from scoping to the board readout. You get the rigour of a global consultancy, the speed of a focused team, and on-the-ground understanding of fast-growing markets such as Saudi Arabia and the UAE.

0+

years of corporate leadership experience behind every engagement

Pharma & biotech
Diagnostics & MedTech
Consumer health
Public health & tenders
DetectTrack competitors, pipelines, deals and policy as they happen
InterpretTurn signals into insight with expert and primary research
DecidePrioritise assets, markets and partners with clear frameworks
ActLaunch, enter and defend with a roadmap leadership can back
Middle East depthRegulators, national tenders and local-content rules across the GCC.
Senior-ledExperienced leaders on every project, from first call to final readout.
Evidence firstBenchmarks built from the ground up and verified with primary research.
AI-poweredAutomated monitoring and AI-assisted synthesis through Connect CIM.
Our Services

End-to-end support across the asset lifecycle

Five practices that take you from the first competitive signal to a successful launch.

1
SignalIntelligence & research
2
StrategyPortfolio & market entry
3
SuccessLaunch & commercial

Competitive Intelligence

Always-on monitoring that tells you what competitors are doing and what it means for you.

CI monitoringLandscape & threatsPipeline trackingCongress coverage
GCC focus

Market Entry & Growth Strategy

Enter new countries with a tested plan, built on the regulatory, tender and partner realities of Saudi Arabia and the Gulf.

Entry strategyTender mappingPartner screeningDue diligence

Portfolio & Asset Strategy

Decide where to invest, which indications to pursue and which partners to bring in.

PrioritisationLicensingTPP strategyLifecycle

Launch & Commercial Excellence

Prepare for launch, stress-test your plan against competitors and win with payers.

Launch readinessWar-gamingPositioningPricing & access

Market Research & Insights

Hear directly from physicians, payers, channels and executives, then size the market.

Physician & payer researchCXO interviewsForecasting
Sectors Pharma & biotech Diagnostics & MedTech Consumer health & telehealth Nutrition Public health Private equity
Case Studies

Impact we have delivered

A selection of engagements for global and regional clients.

FeaturedSaudi ArabiaDiagnostics

Market entry strategy for a global diagnostics leader

A 12-week engagement to define how the client should build its position in a public-sector, tender-driven market.

1Strategic baseline & risk audit
2Entry pathway & partner screening
3Board white paper & phased roadmap
Identified a first-mover opportunity no competitor had captured. The roadmap secured corporate endorsement.
75.6% PUBLIC SECTOR
75.6% public-sector revenue exposure ~46% driven by national tenders
0+tender catalogue lines analysed
0competitors benchmarked
0regulatory bodies mapped
0partners screened
Egypt · KSA · UAE

Commercial due diligence for a private equity investor

~60%stake in a sports nutrition manufacturer assessed
  • ChallengeTest the market and the business plan before investing.
  • ApproachMarket model, channel interviews and peer benchmarking.
  • ImpactGo / no-go framework and a regional growth roadmap.
Global · Rare disease

Competitor assessment for a rare-disease leader

8–10complement pathways mapped across ~10 competitors
  • ChallengeSpot future threats across three therapy areas.
  • ApproachCompetitor profiling and pipeline dashboards.
  • ImpactSharper positioning and lifecycle priorities.
Global · Obesity, NASH, CKD

Drug delivery device strategy for chronic diseases

~80Mautoinjectors a year forecast in obesity by 2036
  • ChallengeChoose the right device for three different indications.
  • ApproachStakeholder workshops, device scoring and forecasts.
  • ImpactGlobal alignment on one scalable platform.
Global · China · Vaccines

Target product profile for an mRNA vaccine

TPPbuilt to avoid the pitfalls of past Phase III failures
  • ChallengeSize the opportunity and define a winning profile.
  • ApproachUnmet-need review, trial history and access analysis.
  • ImpactClear TPP, trial design and China entry route.

Client names are withheld for confidentiality.

New · Connect CIM

Your competitive news, monitored automatically.

Connect CIM is our intelligence monitoring platform. It tracks pharma, MedTech and digital health news around the clock and delivers each story with a clear Precision10X point of view, so your team knows what happened and why it matters.

Automated monitoringNew stories collected continuously
Point of viewExpert take on every story
Source linkedOne click to the original article
Corporate access onlyVerified company email required
PharmaCompetitive intelligenceM&ACollaborationsHealthcareMedTechTelehealthDigital health
Connect CIMSecure
M&ASample story

Headline: what happened, in one line

The body summarises the news: who was involved, the deal or event, and the key numbers your team needs to know.

Point of viewOur take on what this means for competitors, pricing, partnerships and your strategy.
Source: original publisher
CollaborationSample story

Example: a licensing deal expands a competitor's pipeline

Clients see the facts first: the partners, the asset, the therapy area and the deal terms that were disclosed.

Point of viewWhich brands could be affected, how soon, and the questions to raise with your team this week.
Source: original publisher
Digital healthSample story

Example: a telehealth platform launches in a new GCC market

Every story follows the same structure, so your team can scan the day's news in minutes.

Point of viewWhat it signals for channel strategy, access and partnerships in the region.
Source: original publisher
Preview layout
Contact Us

Let's talk about your next decision

Tell us about your question and we will come back with how we would approach it.

Email
LinkedIn
RegionsGCC · India · Europe · US · Southeast Asia